These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9480978)

  • 1. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes.
    Ciupitu AM; Petersson M; O'Donnell CL; Williams K; Jindal S; Kiessling R; Welsh RM
    J Exp Med; 1998 Mar; 187(5):685-91. PubMed ID: 9480978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
    Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
    J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
    Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
    J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.
    Gallimore A; Dumrese T; Hengartner H; Zinkernagel RM; Rammensee HG
    J Exp Med; 1998 May; 187(10):1647-57. PubMed ID: 9584143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
    Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
    J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
    Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
    J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells efficiently induce protective antiviral immunity.
    Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
    J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
    Moskophidis D; Zinkernagel RM
    J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
    Klavinskis LS; Whitton JL; Oldstone MB
    J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope.
    Shams H; Poblete F; Rüssmann H; Galán JE; Donis RO
    Vaccine; 2001 Nov; 20(3-4):577-85. PubMed ID: 11672924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.
    von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL
    J Virol; 1996 Feb; 70(2):1072-9. PubMed ID: 8551565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
    Seiler P; Bründler MA; Zimmermann C; Weibel D; Bruns M; Hengartner H; Zinkernagel RM
    J Exp Med; 1998 Feb; 187(4):649-54. PubMed ID: 9463415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction.
    Rodriguez F; Zhang J; Whitton JL
    J Virol; 1997 Nov; 71(11):8497-503. PubMed ID: 9343207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
    Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
    J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.